GRNA — Greenlight Biosciences Holdings PBC Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $45.43m
- $37.72m
- $6.78m
Annual cashflow statement for Greenlight Biosciences Holdings PBC, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | ||
| Standards: | — | — | USG | USG |
| Status: | fx Preliminary | fx Preliminary | Final | Final |
| Net Income/Starting Line | — | — | -112 | -167 |
| Depreciation | ||||
| Non-Cash Items | — | — | 4.18 | 13.8 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | — | 10.5 | 8.41 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | — | — | -91.8 | -137 |
| Capital Expenditures | — | — | -15.1 | -26.5 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | 0.109 | 0.037 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | — | — | -15 | -26.5 |
| Financing Cash Flow Items | — | — | -3.02 | 78.5 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | — | 45.3 | 201 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | — | — | -63.3 | 37.6 |